Diplomat announces content partnership with National Association of Specialty Pharmacy
Flint, Mich. – Feb. 17, 2014 — Diplomat, the country’s largest independent specialty pharmacy, announced today that it has initiated a content partnership with the National Association of Specialty Pharmacy (NASP).
The new partnership will support Diplomat’s recently launched web platform, diplomat.is, and its goal to be a leading resource for specialty pharmacy. Additionally, the partnership will further establish NASP’s position as a leading voice in specialty pharmacy and clinical news.
“Our goal is to build partnerships within the industry and foster an environment of collaboration to enhance education and improve the care that patients receive,” Gary M. Cohen, BSPharm, RPh, CSP, NASP CEO, said. “We support efforts by our industry partners that allow pharmacists and other stakeholders to gain additional education and knowledge about targeted specialty therapeutic categories.”
The partnership agreement also presents the potential for future growth and opportunities for Diplomat to provide educational materials as well.
“Our partnership with NASP will allow us to share rich, deep content supported and developed by industry experts,” stated Jenny Cretu, Vice President of IT & Marketing at Diplomat. “NASP is committed to providing the highest quality of information for continued education and awareness and we are excited to bring this to our Diplomat patients and partners.”
The National Association of Specialty Pharmacy was founded in 2012. The organization represents specialty pharmacy professionals in all practice settings. The mission of the NASP is to provide educational programs, certification curriculum and professional networking forums to promote the safe and appropriate use of specialty medications.
@DiplomatRxWe are #hiring sales consultants for both NYC and Oakland, California! Come check it out. https://t.co/GDqMaItrsZ5 days ago
@gchabitatRT @gchabitat: Do you have what it takes to be a Habitat Olympian? Join us at @DiplomatRx on 5/5 to find out! https://t.co/5eq5y94hv36 days ago
@DiplomatRxDiplomat Will Dispense ZEJULA™ to Treat Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer… https://t.co/MnQRQdLufl1 week ago
@DiplomatRxFar more than an adventure, their trip was dedicated to assisting people living with #hemophilia… https://t.co/kngmnkvjvU2 weeks ago
@DiplomatRxDiplomat to Release First Quarter 2017 Operating Results and Host Conference Call on Monday, May 8, 2017… https://t.co/h6vJR7823O2 weeks ago